Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Placebo-Controlled Study Comparing the Safety and Efficacy of Adalimumab to Methotrexate and
Placebo in Subjects with Moderate to Severe Chronic Plaque Psoriasis